A simple description of a less understood topic in Intensive Care Medicine. Aim to make understanding and management easy for the residents and prevention steps for all ICU workers.
This is a comprehensive approach to a hypertensive patient presenting to the emergency department.
Discussing:-
- Hypertensive emergency
- Hypertensive Urgency
- Hypertensive Crisis
- Hypertensive encephalopathy and retinopathy
- Accelerated Hypertension
- Malignant hypertension
A simple description of a less understood topic in Intensive Care Medicine. Aim to make understanding and management easy for the residents and prevention steps for all ICU workers.
This is a comprehensive approach to a hypertensive patient presenting to the emergency department.
Discussing:-
- Hypertensive emergency
- Hypertensive Urgency
- Hypertensive Crisis
- Hypertensive encephalopathy and retinopathy
- Accelerated Hypertension
- Malignant hypertension
Management of hypertensive condition in 2020 according to AHA/ASA guidelines. We will discuss the presentation, clinical assessment, investigations, and management of hypertension along with major randomized controlled trials and guidelines.
hepatorenal syndrome is a one of the complication of cirrhosis of liver. It causes hepatic decompensation of liver. It has high risk of mortality. HRS has two types and type 1 usually present as a acute kidney injury. so, at first HRS should exclude from AKI. HRS type 2 present as a refractory ascites. As this has worst prognosis, only valuable management is liver transplantation.
Management of hypertensive condition in 2020 according to AHA/ASA guidelines. We will discuss the presentation, clinical assessment, investigations, and management of hypertension along with major randomized controlled trials and guidelines.
hepatorenal syndrome is a one of the complication of cirrhosis of liver. It causes hepatic decompensation of liver. It has high risk of mortality. HRS has two types and type 1 usually present as a acute kidney injury. so, at first HRS should exclude from AKI. HRS type 2 present as a refractory ascites. As this has worst prognosis, only valuable management is liver transplantation.
Intracerebral hemorhage Diagnosis and managementRamesh Babu
About ICH - Diagnosis and management, Discussed the clinical presentation, evaluation, radiological features and management including recent guidelines
Physician should have a high suspicion to diagnose patient with pulmonary Embolism, this slides will give you precise Diagnosis, Investigation and guideline directed Treatment.
Hypertensive retinopathy is a very important topic for PG examinations of all types. Especially, the fundal changes are important; Keith and Wegner Grading is also a repeated topic in PG. This slide represents all information in a compressed fashion. Have fun!
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
1. SECONDARY HYPERTENSION
CAUSES AND DIAGNOSTIC APPROACH
WITH
MANAGEMENT OF HYPERTENSIVE EMERGENCY
BY : DR. RAJ KISHOR SINGH
JR-2, DEPT OF MEDICINE
2. HYPERTENSION
Current clinical criteria for defining hypertension generally are based on the
average of two or more seated blood pressure reading during each of
two or more out patient visits.
• A recent classification a/c to-AHA/2O17ACC recommend blood pressure
criteria for defining-
• Normal bp
• Elevated bp
• Stage 1 and stage 2 hypertension
*this classification slightly different from JNC7
3.
4. • PRIMARY ESSENTIAL HPERTENSION;
TYPES
• SECONDARY HYPERTENSION
• It accounts for only 5-20% of hypertensive patients
• A specific underlying disorder causing the elevation of blood
pressure.
Essential hypertension is the term applied to the 80-95%of hypertensive
patients in which elevated blood pressure results from complex interaction
between multiple genetic and environmental factors
7. When to suspect secondary hypertension clinically?
•Absence of family history of hypertension
•Severe hypertension > 180/110 mm Hg with onset at age < 20 years or > 50 years
•Difficult-to-treat or resistant hypertension with significant end-organ damage feature
• Combination of pain (headache), palpitation, pallor and perspiration (phaeochromocytoma)
•Polyuria, nocturia, proteinuria or hematuria – indicative of renal disease
• Absence of peripheral pulses, brachiofemoral delay and abdominal or peripheral vessel bruits
•History of polycystic renal disease or palpable enlarged kidney
•Cushingoid features, multiple neurofibromatosis
•Significant elevation of serum creatinine with use of ACE inhibitors
•Hypertension in children
•History of snoring, daytime somnolence, obesity, short and thick neck – Obstructive Sleep Apnea
8. 1. Renal parenchymal diseases
Renal diseases is the most common causes of secondary hypertension.
Secondary HTN is more severe in glomerular diseases than in interstitial diseases.
Proteinuria >1000mg/day and an active urine sediments are indicator of PRIMARY
RENAL DISEASE
CAUSES-
1. Glomerulonephritis
2. Pyelonephritis
3. Neprocalcinosis
4. Polycystic kidney disease
5. Neoplasm
6. Analgesic nephropathy
7. Gout with renal failure
8. Obstructive nephropathy
.
9. 2. Renovascular hypertension
Renal artery stenosis is also a common cause of secondary hypertension with 2%
prevalence
The most common cause of renovascular hypertension in India is Takayasu’ disease –a
progressive aortoarteritis.
Takayasu’s disease is a non-specific pan arteritis affecting MOSTLY young women.
Hypertension is mainly due to renal artery stenosis which can be unilateral or bilateral
• The most common cause of renovascular disease in Western population are
atherosclerotic disease in 60% of elderly population and fibromuscular dysplasia in
35% of young
• Fibromuscular dysplasia sometimes produce total occlusion and can be associated
with renal artery aneurysm.
• Atherosclerotic disease cause the proximal segment renal artery stenosis and
fibromuscular dysplasia involves the distal segment of renal artery.
11. Renal artery stenosis is more likely if-
• Hypertension is severe, of recent onset or difficult
to control
• Kidneys are asymmetrical in size
• Pulmonary edema occurs repeatedly
• Unexplained deterioration of renal function or detrition of
renal function on ACE inhibitor/ARB.
Diagnostic approach to renovascular hypertension
12. • A paraumbilical bruit is heard in 50-60% of patients with renovascular hypertension and 10%
cases of essential hypertension. A diastolic renal bruit is more specific than systolic bruit.
• Wherever there is a high degree of suspicion, direct selective renal arteriography is
recommended.
• Colour Doppler Ultrasound (CDUS), CT angiography and Gadolinium contrast-MRI angiography
are other good and non-invasive modalities. MRI angiography has higher sensitivity (90%) and
specificity (92%).
• 99Tc – DTPA and I-131 – orthoiodohippurate scan are useful non-invasive investigations.
• CONTRAST ARTERIOGRAPHY remains the gold standard for evaluation and identification of
renal artery lesion . Intra-arterial injection with digital subtraction angiography (DSA) may be
used.
13. 3.Primary Aldosteronism
• Definition:Primary aldosteronism is due to excess aldosterone secretion by the
adrenal cortex ,secreted generally by adenomas and occasionally due to bilateral
adrenocortical hyperplasia.
• The prevalence varies from <2%- 15% of hypertensive individual. This is potentially
curable form of hypertension.
• In these pt. increased aldosterone production is independent of renin-angiotensin
system and the consequences are;
1) Sodium retention
2) Hypertension
3) Hypokalemia
4) Low Plasma renin activity(PRA)
14. • Generally diagnosed at age of 30 -50 years.
• Mostly asymptomatic ; however infrequently, headache, muscle
cramp,polyuria,polydipsia,paresthesias or muscle weakness may be present as
consequences of hypokalemic alkalosis. Hypertension usually mild-moderate but
occasionally may be severe.
• suspected in a case of hypertension showing persistent hypokalemic metabolic
alkalosis in the absence of diuretic therapy.
Screening Test
a) Plasma Aldosterone to Plasma Renin Activity (PA/PRA) ratio >30:1 (normal < 10) is 90%
sensitive and 91% specific for Primary Hyper Aldosteronism.
b) Unprovoked hypokalemia(<3.1mmol/L)
.
15. Diagnosis
• Confirmed by –demonstrating failure to suppress plasma aldosterone to
<227pmol/L(<10ng/dl) after IV infusion of 2Lof isotonic saline over 4 hour.
• Alternatively confirmed by failure to suppress aldosterone in response to oral
NaCl load,fludrocortisone,or captopril.
It is usually diagnosed by imaging techniques.
a) CT /HRCT if CT is not diagnostic, then we do
b) Adrenal scintigraphy with 6β-[I131] iodomethyl-19-norcholesterol after
dexamethasone suppression(0.5mg every 6hr for 7 days)
16. 4. CUSHING’S SYNDROME
• Hypertension occurs in 75-80% of patients with Cushing syndrome.
• The mechanism may be related to stimulation of mineralocorticoid receptor by
cortisol and increased secretion of other adrenal steroids.
• This syndrome is related to excess cortisol production due to either ACTH
secretion (from pituitary tumor or an ectopic tumor) or
ACTH independent adrenal production of cortisol as well as
administration of exogenous glucocorticoid.
18. Cushing syndrome : Diagnosis
Screening test;
• 24 hr. urine free cortisol :>90ug/day is 100%sensitive and 98% specific.
• Recent evidences suggests that late night salivary cortisol(>5nmol/L) is also
a sensitive and convenient screening test
Confirmatory test-
• Low dose dexamethasone suppression test – Give 1mg dexamethasone at
11 p.m. and draw a sample of blood at 8 a.m. for cortisol measurement
{>50nmol is +ve.}
• CT /MRI SCAN of head (pituitary) and chest (ectopic ACTH TUMOR)
19. 5. PHEOCHROMOCYTOMA
• This is uncommon found in approximately 2 individuals per million
population.
• Pheochromocytoma is catecholamine secreting tumor of adrenal medulla
• Hypertension is primary related to increased circulating catecholamine
(norepinephrine,neuropeptide y) and other vasoactive substance but in few
cases epinephrine is main catecholamine which produce hypotension rather
than hypertension.
20. Pheochromocytoma
Essential of dignosis
• Attack of headache, profuse sweating, episode of palpitation (constitute classical
triad) sustained or paroxysmal hypertension ,anxiety and feeling of impending
doom
• Laboratory testing consists of measuring catecholamine in either using
a) 24 hr. urinary metanephrine excretion
b) Fractionated plasma free metanephrines.
• CT and MRI are both in similar sensitivity of imaging adrenal tumor
• while T2 weighted MRI with gadolinium contrast is better than CT in extra adrenal
tumor.
• MIBG labelled with I-131 is the most specific way of diagnosing adrenal and extra
adrenal pheochromocytomas and PET scan using 18-F flurodeoxyglucose(FDG) is
also useful.
21. 6.Coarctation of aorta
• most common congenital cardiovascular cause of hypertension
• 35% of children is associated with Turner syndrome.
• Coarctaion of aorta consists of localized narrowing of aortic arch just distal to the
origin of the left subclavian artery.
Clinical presentation-
• differential systolic BP in arms and leg
• diminished/absent femoral artery pulse
• May be differential BP in arms if defect is proximal to left subclavian artery.
Diagnosis- may be confirmed by chest x-ray and trans esophageal
echocardiography.
Therapeutic options include surgical repair and balloon angioplasty.
23. Miscellaneous cause of Secondary hypertension
Obstructive sleep apnea
The severity of hypertension correlates severity of sleep apnea. Diagnosis can be
confirmed by polysomnography.
Weight loss and administration of continuous positive airway pressure (CPAP) or bi-level
positive airway pressure(BiPAP) during sleep is an effective therapy.
Hypertension during pregnancy is usually caused by PreEclampsia Eclampsia , and gestational
hypertension.
OCP/ESTROGEN:A small increased in BP occurs in most women taking Estrogen or oral contraceptive.
This is caused by volume expansion due to increased angiotensinogen and consequent
activation of RAAS .
Thyroid disease- mild diastolic hypertension in hypothyroidism, where as hyperthyroidism causes
systolic hypertension.
Acute stressful situations cause intense sympathetic discharge and may temporarily induce
hypertension.
Common conditions include Hypoglycemia, exposure to cold, burns, perioperative period and post
head injury
Drugs: NSAID, sympathomimetic amines, glucocorticoids, cocaine and amphetamines can all cause
significant hypertension.
25. What is hypertensive emergency?
• Hypertensive emergencies are abrupt, severe elevations in blood pressure,
in a patient with underlying hypertension or related to sudden onset
hypertension in previously normotensive individual.
• systolic blood pressure [SBP] greater than 180 mm Hg and/or
• diastolic blood pressure [DBP] greater than 120 mm Hg) associated with the
presence of target-organ dysfunction
Emergency includes ;
• Hypertensive encephalopathy(headache ,confusion, alter mental status)
• Hypertensive nephropathy(hematuria, proteinuria, and acute kidney injury)
• Progressive retinopathy
26. How Hypertensive emergency is different from urgency?
Hypertensive emergency
• Symptomatic severe hypertension
• Presence of acute end organ
damage
• BP reduced within minutes to
hour.
Hypertensive urgency
• Asymptomatic severe hypertension
• Absence of acute end organ damage
• BP reduced within a few hr.
27. Goal of therapy
Goal time BP Target
• First hour Reduce MAP(mean arterial pressure) by no more than 25%
• 2–24 hour maintain SBP 160 mm Hg and/or DBP 110 mm Hg
• 24–48 hour Outpatient BP goals according to the 2017 JNC
Guidelines for Management of High Blood Pressure.
Initially in Patients without encephalopathy or any catastrophic event, it is preferable to
reduce BP OVER an hour or longer with frequent dosing of short acting oral agent
such as
captopril, clonidine and Labetalol.
Excessive reduction of BP may precipitate Renal , coronary, cerebral ischemia.
28. A few hypertensive emergencies with preferred I.V DRUGS.
A)Hypertensive encephalopathy;
• I.V nitroprusside : short acting vasodilator with a rapid onset of action that allows for minute
to minute control of blood pressure.
• I.V Labetalol and Nicardipine are also effective agent.
B)Stroke- recommended drugs are – I.V NICARDIPINE, LABETALOL, NITROPRUSSIDE
a)Acute ischemic stroke :
In such cases antihypertensive should only be used if
SBP >220 mmhg or DBP >130 mmhg
If thrombolytic are to be given BP should be maintained at <185/110.
b) Hemorrhagic stroke : antihypertensive should be started if systolic
BP>180 mmhg ,or diastolic BP >130 mmhg.
c) subarachnoid hemorrhage - antihypertension management is controversial.
30. Usual intravenous dose of antihypertensive agent.
Labetalol
• 20 mg iv over 2 minute then 40-80 mg at every 10 min interval up to 300 mg total till
target BP is achieved.
• Total dose should not exceed 300 mg.
• 1-2 mg /min infusion till bp is achieved.
Nitroprusside
• Initial 0.3 µgm/kg/min to 10 µgm/kg/min. for every 10 min.
Nitroglycerin
• 5-20 µgm/min. in infusion ,then titrated by 5 µgm/min. at every 3-5 min. interval.